Dr Reddys Labs Launches Generic Sapropterin Dihydrochloride Tablets

Dr Reddys Labs Launches Generic Sapropterin Dihydrochloride Tablets

Dr Reddy'S Laboratories Ltd Announced The Launch Of A Generic Version Of Sapropterin Dihydrochloride Tablets, For Oral Use."We Are Pleased To Launch This Generic Version Of Sapropterin Dihydrochloride Tablets, For Oral Use, Illustrating Our Continued Commitment To Bring Affordable Generic Medicines To Market For Patients," Says Marc Kikuchi, Chief Executive Officer, North America Generics, Dr Reddy'S Laboratories."At The Same Time, This Product Demonstrates That We Are Actively Expanding The Breadth Of Our Portfolio With A Treatment For A Rare Disease. We Are Pleased To Provide Financial Support To Patients By Offering A Co-Pay Card Program For Eligible Patients, Details Will Be Available On Our Website," Added Kikuchi.Dr Reddy'S Sapropterin Dihydrochloride Tablets, 100 Mg Are Available In Bottle Count Sizes Of 120.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!